# Borate-based Bioactive Glass Fiber Matrix (BBGFM) in the Treatment of Venus Leg Ulcers (VLU)

> **NCT07647705** · NA · NOT_YET_RECRUITING · sponsor: **ETS Wound Care, LLC** · enrollment: 110 (estimated)

## Conditions studied

- Venus Leg Ulcer (VLU)
- VLU
- Venus Leg Ulcer
- Venus Ulcer

## Interventions

- **DEVICE:** Borate Based Bioactive Glass Fiber Matrix (BBGFM)

## Key facts

- **NCT ID:** NCT07647705
- **Lead sponsor:** ETS Wound Care, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2027-01
- **Final completion:** 2028-01
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2026-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07647705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07647705, "Borate-based Bioactive Glass Fiber Matrix (BBGFM) in the Treatment of Venus Leg Ulcers (VLU)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07647705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*